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Abstract— Contrast echocardiography (CE) ultrasound with
microbubble contrast agents has significantly advanced our capa-
bility for assessment of cardiac function, including myocardium
perfusion quantification. However, in standard CE techniques
obtained with line by line scanning, the frame rate and image
quality are limited. Recent research has shown significant frame-
rate improvement in noncontrast cardiac imaging. In this work,
we present and initially evaluate, both in vitro and in vivo,
a high-frame-rate (HFR) CE imaging system using diverging
waves and pulse inversion sequence. An imaging frame rate
of 5500 frames/s before and 250 frames/s after compounding
is achieved. A destruction-replenishment sequence has also been
developed. The developed HFR CE is compared with standard
CE in vitro on a phantom and then in vivo on a sheep heart. The
image signal-to-noise ratio and contrast between the myocardium
and the chamber are evaluated. The results show up to 13.4-dB
improvement in contrast for HFR CE over standard CE when
compared at the same display frame rate even when the average
spatial acoustic pressure in HFR CE is 36% lower than the
standard CE. It is also found that when coherent compounding is
used, the HFR CE image intensity can be significantly modulated
by the flow motion in the chamber.
Index Terms— Contrast-enhanced ultrasound (CEUS) imaging,
high-frame-rate echocardiography, in vivo, myocardium perfu-
sion, ultrafast diverging beams.
I. INTRODUCTION
M ICROBUBBLES for contrast-enhanced ultrasound(CEUS) imaging are bringing new information in clin-
ical practice and preclinical research [1]. These microbub-
bles, or ultrasound contrast agents (UCAs), typically have
a similar size (of the order of microns) to red blood cells
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with a gas core encapsulated by a phospholipid, albumin, or
polymer shell. These bubbles are highly sensitive to ultra-
sound, thanks to their radial oscillations and resonant behavior,
and once introduced into the blood stream intravenously,
they can generate significant signal enhancement. Various
signal processing techniques have been developed in order to
achieve sensitive, specific, and quantitative imaging of UCA
for flow and perfusion imaging [2], [3]. CEUS has shown
great potential in the diagnosis and management of a range of
cardiovascular diseases and cancer, and is gaining increasing
acceptance clinically [1], [4]. Furthermore, the shells of the
bubbles can be functionalized to target-specific molecule(s) of
interest on the vascular endothelial wall, achieving ultrasound
targeted/molecular imaging [4]. More recently, CEUS using
low concentration of microbubbles, combined with localization
of spatially isolated microbubbles, has been able to achieve
subwavelength structural imaging of microvessels [5], [6].
Another significant advance in biomedical ultrasound is
the development of high-frame-rate (HFR) US imaging tech-
niques [7]. HFR US, with parallel data acquisition and digital
beamforming, enables a frame rate of up to tens of thousands
of images per second and offers exciting opportunities for
US imaging. Indeed, recently HFR US has been applied to
track fast shear waves in soft tissue elastography [8], [9],
cardiac ultrafast 3-D Doppler imaging [10], cardiac strain
imaging [11], blood flow velocity mapping [12], and brain
functional imaging [6].
HFR CEUS, which combines CEUS with HFR US, can take
advantage of both techniques and offer a unique opportunity
for extracting new clinical information with improved US
imaging capability. This is an exciting new area of research,
and only a limited number of initial studies have been reported
using clinical high-frequency linear probes on noncardiac
applications. In [13] and [14], HFR CEUS has been shown
to significantly expand the capability of existing nonlinear
Doppler techniques in imaging both flow and perfusion from
limited field of view to the full field of view. Couture and
his colleagues have observed in vitro reduced bubble destruc-
tion [15] and improved imaging contrast [16] in HFR CEUS
compared to the focused approach. We have demonstrated that
HFR CEUS using plane wave transmission, combined with
spatial and temporal signal processing, is able to produce
This work is licensed under a Creative Commons Attribution 3.0 License. For more information, see http://creativecommons.org/licenses/by/3.0/
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significantly improved vascular images in vivo [17]. Similar
results have been observed by evaluating the impact of the
flow velocity on the coherent compounding of plane wave
amplitude modulation transmission [18]. We have recently
demonstrated the use of HFR CEUS and image tracking
for ultrasound imaging velocimetry (also called echo-particle
imaging velocimetry) to map arterial flow and wall shear
stress [19] and in visualizing the flow profile by controlled
destruction of a volume of bubbles and observing the resulting
bubble void subsequently evolve within the flow using HRF
CEUS [20]. More recently, ultrasound superresolution of a rat
brain has been demonstrated using HFR CEUS [6].
Non-HFR contrast echocardiography (CE) techniques have
been developed [21] and extensively evaluated clinically [22]
for myocardium perfusion quantification, thanks to the sensi-
tivity offered by UCA. The ability to visualize and quantify
perfusion defects in the myocardium is valuable for both
diagnosis and treatment monitoring of, e.g., coronary artery
disease. Typically, a relatively high amplitude ultrasound pulse
is used to disrupt UCA within the imaging plane, followed by
low-amplitude ultrasound pulses for monitoring replenishment
of flow within the tissue. However, the key challenges in
perfusion measurement are image quality. As reported in [23],
physicians must become familiar with the criteria of an ade-
quate contrast echocardiogram as well of artifacts to obtain
the best contrast for left ventricular (LV) and myocardial
opacification for myocardium perfusion assessment. Other-
wise, it makes the technique highly operator dependent and
limits its use. On the other hand, CE is routinely used clinically
for significantly improved delineation and tracking of endo-
cardium boundary in the LV, which compared to conventional
ultrasound has shown to significantly increase the accuracy of
the measurement of ejection fraction [23], [24]. The under-
standing of blood flow patterns within the heart chambers
remains an under investigated area, however, which may
provide additional heart function information [23], [25], [26].
This may partly be attributed to the inadequate temporal
information and field of view that conventional CE is able
to capture [25], [26].
Furthermore, noncontrast-enhanced cardiac HFR US tech-
niques have also been developed using multiline acquisi-
tion [27], multiline transmission [28], [29] and diverging wave
transmission [9], [30]–[34]. Multiline acquisition is based on
the transmission of a wider focus beam and the creation of
several received lines from the same transmission. The mul-
tiline transmission approach is the simultaneous transmission
of focused waves at the same time. It improves the frame
rate of the standard focused transmission by the number of
multitransmissions. The best result is obtained by transmitting
four focused transmissions at the same time and may also
be used for tissue Doppler imaging [29], [35]. Diverging
transmission is the successive transmission of unfocussed
ultrasound waves using a virtual point source behind the
probe and the coherent sum of the radio frequency (RF)
images obtained in order to improve the image quality as in
plane wave transmission [8], [31]. Diverging transmission has
been used for tissue Doppler (250 frames/s) and vortography
with motion correction [33], [34], Doppler imaging of the
left ventricle (4800 frames/s) [32], and shear wave elas-
tography by combining diverging transmission with pulse
inversion (PI) (>1500 frames/s) [9]. Two kinds of diverging
transmission have been proposed. In [9] and [31], the diverging
waves are obtained by using a subaperture of the probe and the
virtual source is placed at the center of the subaperture. Then,
the subaperture is shifted a few elements, and this operation is
repeated spanning along the length of the probe. In [9], [30],
and [32]–[34], diverging waves are still obtained with a virtual
point source but with the full aperture of the probe. The virtual
source is moved behind the probe in order to create different
diverging waves.
In [11], an overview of cardiac noncontrast-enhanced
HFR US is given, including B-mode imaging improve-
ment [28], [30], Doppler for tissue and LV ima-
ging [32]–[34], [35] or blood flow dynamics in the
myocardium using plane wave ultrafast Doppler imaging [36],
neonatal hearts flow patterns tracking using speckle
tracking [37], and motion and deformation imaging, shear
waves, and tissue velocities calculation [9], [31]. Usually,
these methods are implemented during postprocessing due
to the high calculation power required. However, new
echography research scanner are now capable to process
calculations for vector Doppler and plane waves imaging in
real time for a fastest interpretation [38].
The noncontrast-enhanced techniques presented above do
not have as good a sensitivity to blood flow as that of CEUS,
and it is very difficult if not impossible to use them to image
myocardium perfusion. A further problem of noncontrast-
enhanced cardiac HFR US is the difficulty in achieving similar
levels of acoustic pressure at depth due to the lack of focusing
during transmission.
Here, we present and initially evaluate both in vitro and
in vivo an HFR CEUS system for imaging cardiac structure
and flow and myocardium perfusion; following a recent pre-
liminary study, we have reported at the IUS 2016 conference
and a letter demonstrating the feasibility in-human [39], [40].
Compared to the in-human demonstration study, this study
offers an in-depth description of the technical methodology,
and a comprehensive evaluation of the techniques compared
with traditional CE. The technique takes advantage of both
UCA and HFR US, promising unprecedented imaging contrast
and signal-to-noise ratio.
II. MATERIALS AND METHODS
An HFR CE system based on a 128-Verasonics platform
(Verasonics Inc., Redmond, WA) mounted a phased-array
transducer (ATL P4-1, Phillips, Seattle, Washington) having
96 elements with a pitch of 295 µm and a central frequency
of 2.5 MHz was developed. Performance was initially evalu-
ated on both an in vitro phantom and in vivo.
A. Ultrasound Transmission Sequences
Three transmissions based on high-frame-rate imaging and
classic line-by-line scanning approach were designed: HFR
CE transmission, conventional CE transmission, and UCA
destruction transmission.
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Fig. 1. (a) HFR CE angle transmission and (b) transmission sequence for real-
time display and destruction-replenishment acquisition in vitro and in vivo.
1) High-Frame-Rate Contrast Echocardiography Transmis-
sion: The HFR CE imaging proposed here is defined by the
coherent sum of PI diverging waves. Each diverging wave
was obtained by defining a virtual source located behind the
transducer to cover a large illumination area. The distance of
the virtual source was linked to the full aperture and to an
angular tilt angle α and width β which were defined by [33]
and illustrated in Fig. 1(a). The angular tilt α defines the angle
step of each compounding angles while β corresponds to the
area illuminated.
In order to obtain a compounded image, the tilt angle α was
varied while the angular width β was set constant. A 90° angu-
lar width was chosen corresponding to the angular aperture of
the phase array probe. For each angle, two successive pulses
in opposite phase were transmitted, recorded, and combined
in postprocessing to form the PI image. Moreover, because
of a possible nonperfect cancellation of the fundamental
component due to the movement, a high pass zero-phase fifth-
order Butterworth filter with a cutoff frequency at 2.7 MHz
was used in order to extract the second-harmonic signal of
the PI
2) Conventional Contrast Echocardiography Transmission:
The CE transmission used corresponds to the CE imaging used
in most existing ultrasound scanners: line-by-line scanning.
CE transmission is combined to the MLA beamforming
approach to reconstruct several lines simultaneously for each
transmit pulse [27]. One CE image is obtained after the
successive transmission of focused waves along an angular
width (i.e., 90°). For each angle step, two low amplitude pulses
in opposite phase are successively transmitted, recorded, and
results combined to form the PI image. The same filter as
HFR CE was used to extract the second-harmonic signal from
PI images. The frame rate achieved was 30 Hz for a depth
of 13 cm.
3) UCA Destruction Transmission: The UCA destruction,
commonly used for measuring tissue blood replenishment
(clinically termed “destruction-replenishment” or “destruction-
reperfusion” method), is achieved by transmitting a focused
21-cycle burst signal of high intensity. While still well within
the safety limit for ultrasound imaging, such a transmission is
designed to destroy the UCA in the region of interest (ROI),
i.e., the myocardium, and then allow the capture of replenish-
ment of UCA within the same ROI.
4) Transmission Sequence Description: Two imaging trans-
mission sequences are created, by combining destruction
transmission with either HFR CE transmission or classic CE
transmission, with a common timing as shown in Fig. 1(b). The
preacquisition display, before and after destruction sequences
correspond to either the classic CE or HFR CE. Before the
TABLE I
TRANSMISSIONS PARAMETERS USED DURING
In Vitro AND In Vivo EXPERIMENTS
Fig. 2. Peak-negative pressure as a function of depth for HFR CE and CE and
corresponding area for the ratio of average pressure between CE and HFR CE.
destruction of the UCA, several frames are saved in order
to compare the intensity before and after the destruction.
Only the before destruction acquisition was used for in vitro
experiments as the phantom was not dynamic, while the full
sequences were used for in vivo experiments. Transmission
parameters for both experiments are given in Table I. In order
to achieve a frame rate of 30 Hz, CE transmission has an
angle step of 1.1° which is not optimal for contrast imaging.
Thus, MLA beamforming is processed to double the line
density. The peak negative pressure as a function of depth
of CE and HFR CE transmission is shown in Fig. 2. The
peaks negative pressure of the sequences was measured in
water using a calibrated hydrophone (Precision Acoutisc) with
a derating factor of 0.3-dB cm−1 MHz−1. The same peak
negative pressures at 80 mm, given in Table I and corre-
sponding to the CE focus depth, have been used for in vivo
and in vitro experiments. Fig. 2 also shows the corresponding
areas used in order to calculate the ratio of average pressure
between CE and HFR CE. The ratio is obtained by calculating
the ratio of the integrals of each curve. The minimum and
maximum depths for the integrals have been selected based on
the position of the myocardium during the in vivo acquisitions.
It highlights that each HFR CE transmission has 36% lower
average peak-negative pressure compared to CE.
B. In Vitro Experimental Setup
A tissue mimicking phantom, consisting of polyvinyl
alcohol (PVA) with a circular chamber, was developed for
evaluating the HFR CE method. The center of the circular
chamber is at 65 mm, and its diameter is about 30 mm. The
tissue mimicking phantom was composed of (percentage of the
total weight): PVA 10% (363146; Sigma-Aldrich), water 89%,
and glass beads 1% (45–90 µm). The water was heated
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at 90 °C, and PVA and glass beads were added slowly and
cooked (with mixing) during 1 h. The mixture was left to cool
at least 4 h for degasing. Then, three freeze–unfreeze cycles
of 24 h each were realized [41]. The PVA phantom was then
stored in a plastic box with water and detergent in a fridge.
The 30 min before experiment, the phantom was removed from
the fridge and washed and warmed. The phantom was set in
a water tank filled with 20 L of water (24 °C) and 0.5 ml
of Sonovue UCA (1/40 dilution) was mixed using a magnetic
stirrer. All acquisitions lasted in total 6 min and during each
transmission, the mixing was stopped.
C. In Vivo Sheep Heart Experimental Setup
The in vivo CE experiment was conducted under license
from the U.K. Home Office at the University of Edinburgh,
Edinburgh. The CE HFR was evaluated in vivo on an adult
female Scottish Greyface sheep under terminal general anes-
thesia maintained using isofluorane [42]. The probe was held
using a metallic arm in order to capture the same image
of the left ventricle. The sheep was positioned slightly on
the left side that ensured optimal heart imaging and avoided
reflections from the ribs. During the acquisition, ventilation
was transiently paused by extubation to avoid chest movement.
One conventional CE transmission and three HFR CE
acquisitions were made on the same sheep with using one
bolus injection of 1.2-mL Sonovue UCA followed by 7 mL of
saline solution flush for each acquisition. The data acquisition,
(baseline, destruction, and subsequent imaging) started 1 min
after each bolus injection.
D. Postprocessing and Analysis
1) Image Postprocessing: In order to reduce noise and
improve signal-to-noise ratio, an incoherently averaging in
function of time of the HFR CE frames is applied in post-
processing. The frame rate of HFR CE is improved by a factor
of 8 compared to the conventional CE.
Averaging seven envelope-detected HFR CE frames, with
a triangular window centered on the interested frame, corre-
sponds to a similar frame rate as the standard CE transmission.
However, by doing an overlap time average, the same number
of frames is obtained after the temporal filter. The image is
named HFR CE SUM 7 in the figures while named SUM 7
in the paper.
2) Image Quality Evaluation: The image quality improve-
ment is evaluated in vitro by measuring the contrast between
the PVA tissue and the UCA and in vivo by measuring
the contrast between the myocardium and UCA inside the
chamber. The contrast evaluation is based on two equations:
the contrast-to-acoustic-noise ratio (CANR) approach and the
contrast-to-tissue (CTR) ratio. They are, respectively, defined
as [43]–[45]
CANR = |µROI − µTissue|√
σ 2ROI + σ 2Tissue
(1)
CTR = 20 log10
(
µROI
µTissue
)
(2)
where in (1) µROI and µTissue are the mean in an ROI (usually
a cyst) and the surrounding tissue. σROI and σTissue are their
Fig. 3. PI images (a)–(c) without and (d)–(f) with microbubbles in the circular
chamber of the PVA phantom for focused (a) and (d) CE, (b) and (e) HFR CE,
and (c) and (f) HFR CE SUM 7. The white boxes in (d) are used to evaluate
the NWP through the UCA. The black dashed box and the area between the
two white ellipses in (e) show the microbubbles and tissue ROIs used for
calculating CANR and CTR, respectively. Each image is normalized by its
own maximum intensity and displayed with a dynamic range of 40 dB. Images
are displayed between 20 and 100 mm and the lateral axis cover 100 mm.
corresponding standard deviations. In (2), µROI and µTissue are
the backscattered signals of the UCA and tissue, respectively.
Both equations are used for data analysis. For in vitro data,
the ROI corresponds to the black box in the circular chamber
containing UCA and the tissue region is the area between
the two white ellipses. For in vivo data, the ROI and the
tissue correspond to the cardiac chamber containing UCA and
the myocardium divided into different segments, respectively.
The myocardium segmentation was obtained using a fully
automatic myocardial segmentation based on random forests
guided by shape model [46]. Then, the myocardium segmen-
tation is divided into six segments in order to evaluate the
contrast at several depths.
The effect of nonlinear wave propagation (NWP) in ultra-
sound contrast agent is also evaluated in vitro for both trans-
missions. The NWP effect is calculated such as
NWP = (µTissue Propagation − µUCA Propagation) (3)
where µTissue Propagation and µUCA Propagation are the mean inten-
sity, at the same depth in the lower part of the tissue phantom,
away and below the UCA area, respectively.
CANR, CTR, and NWP are calculated for each acquisition
frame (Table I), and their corresponding mean and standard
deviation are provided.
3) Analysis of Destruction-Replenishment Data: In vivo
destruction-replenishment analysis was evaluated from the
time-intensity curve (TIC), and it is measured by using the
myocardium segmentation described previously. The TIC is
fit using the lognormal model proposed in [47] allowing the
quantification of the disruption replenishment.
III. RESULTS
A. In Vitro Experimental Setup
Fig. 3 shows one frame of the PVA phantom for conven-
tional (a) and (d) CE, (b) and (e) HFR CE, and (c) and
(f) SUM 7 acquisition. The images in the top of Fig. 3 are
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Fig. 4. CANR and CTR of the in vitro experiments calculated at several
positions shown in Fig. 3(b). The bold values are the percentage or difference
of improvement compared to the CE approach.
Fig. 5. (a) CE , (b) HFR CE (slow and fast frame rates), and
(c) HFR CE SUM 7 (slow and fast frame rates) images of in vivo
heart sheep experiments. CE and HFR CE are two successive acquisitions at
the same position. All images are normalized and log compress by their own
maximum and display with a dynamic range of 40 dB. The maximum depth
is 90 mm and the lateral axis cover 100 mm.
without UCA while the images in the bottom are with UCA.
Fig. 3(d) shows the areas where the NWP effect is evaluated,
and Fig. 3(e) shows the UCA (black box) and tissue (zone
between the two white ellipses) areas used for CANR and
CTR evaluation.
With UCA, the contrast between the tissue and UCA is
better for the HFR CE and SUM 7 than conventional CE.
This is shown in Fig. 4, where CANR and CTR for the
proposed HFR method are up to 48% and 13.4 dB higher
than conventional CE method, respectively. For SUM 7, the
CANR and CTR are similar to HFR CE because tissue
and UCA are stationary, so the mean intensity and standard
deviation vary similarly. The NWP effect calculated in the
lower part of the phantom for CE, HFR CE, and HFR CE
SUM7 is about 5.19± 0.15, 7.12± 0.28, and 6.74± 0.15 dB,
respectively. It shows that the NWP effect is up to 1.48 dB
higher for HFR CE than in CE transmission, reducing the
contrast below the cyst area.
B. In Vivo Sheep Heart Experimental Setup
1) Evaluation of Image Quality: Fig. 5 shows one frame
of the in vivo sheep acquisition for the conventional CE,
HFR CE, and SUM 7 approaches. Five supplementary videos
for Fig. 5 are available online. They correspond to the CE,
HFR CE, and SUM 7 approaches. The HFR CE and SUM 7
videos are displayed in a slow and at a fast frame rate.
The central part of each image in Fig. 5 corresponds to the
left ventricle which is filled with UCA. The darker area around
the left ventricle is the myocardium. In conventional CE,
the energy distribution is more concentrated at the focus
(Fig. 2), improving the detection of the myocardium bound-
aries in this area compared to the top the myocardium which
is not delineated as well as for the HFR CE approach. The
visual delineation of the myocardium is improved by using
temporal averaging filters in SUM 7.
Fig. 6. (a) and (b) CE and (c) and (d) HFR CE SUM 7 images of in vivo
heart sheep experiments at systole (left) and diastole (right). The white squares
and yellow segments show the microbubble and myocardium areas used for
CANR and CTR.
Fig. 7. CANR (top) and CTR (bottom) of the in vivo experiments calculated
at several positions shown in Fig. 6. The bold values are the percentage of
difference of improvement compared to the CE approach.
Fig. 6 shows the in vivo images with the myocardium
segmentation obtained corresponding to the ROIs where the
contrast between the myocardium and the chamber was eval-
uated. Two different phases of the heart cycle are provided
(systole and diastole) in order to highlight the variation of the
myocardium shape. The white squares and yellow segments
show the microbubbles and myocardium areas used for CANR
and CTR. The myocardium is divided into six segments,
numbered in Fig. 6(a), and the corresponding quantification
results are given in Fig. 7. The local peak negative pressure
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TABLE II
LOCAL PEAK-NEGATIVE PRESSURE (P−) AND MI AT THE DEPTH
POSITION OF EACH In Vivo MYOCARDIUM SEGMENTS
and mechanical index (MI) corresponding to each segment for
both transmission are given in Table II.
Fig. 7 shows that HFR CE improves the CANR and the
CTR for the first fourth myocardium segments compared to
the conventional CE. At the depth of the third segment, the MI
of both transmissions is similar (Table II) and HFR CE is
about 15% (1.2 dB) and 3.6 dB higher for CANR and CNR,
respectively. In the lower ROI positions, the contrast is lower
because it is close to the focus depth of the conventional CE
with the highest local MI (Table II). Using temporal filter,
the CANR in SUM7 is further improved for the first segments.
2) Destruction-Replenishment Analysis: Fig. 8 shows (left)
the first HFR CE and HFR CE SUM 7 acquisition with
their corresponding myocardium detection images at several
times. The overall segmentation is used to evaluate their
corresponding disruption-replenishment TIC, and there are
shown in Fig. 8 (top right). Fig. 8 (bottom right) shows
the three HFR CE disruption-replenishment TICs acquired
successively and their corresponding lognormal fit.
The TIC normalized curves obtained for the HFC CE and
SUM 7 have the same shape, even if SUM 7 is slightly
smooth, as well as the lognormal curve fit. In the second
TIC graph, the three HFR CE acquisitions look similar with
a replenishment after the destruction of the microbubbles.
Moreover, a regular sinusoidal pattern (every 0.53 s) is present
corresponding to the heart cycle around 110 bpm.
IV. DISCUSSION
This paper presents in vitro and in vivo studies on HFR CE
imaging methodology. It takes advantage of the high temporal
resolution of HFR imaging and the high sensitivity of CEUS
using ultrasound contrast agent, for imaging cardiac flow and
myocardium perfusion. The main aim of this study is to evalu-
ate any improvement in image quality and temporal resolution
obtained for CE acquisition using diverging waves and PI
approaches over existing focused transmission approaches.
The results from both in vitro and in vivo experiments
show that compared to the existing standard focused CE
process with two parallel beams in reception, HFR CE can
generate higher CANR thanks to its higher imaging frame rate
that allows using a combination of coherent and incoherent
compounding.
While image resolution may decrease by the diverging wave
imaging as there is no transmission focus, through multiangle
transmission and beamforming with coherent compounding,
focusing in both transmit and receive at every depth can
be synthesized in HFR CE [30], [31]. In [33], an optimal
HFR B-mode transmission combined to a motion estimation
and correction has been proposed. In this proposed study,
a tradeoff between grating lobes and frame rate has be made
especially in contrast mode where twice more transmissions
are required than B-mode imaging. A consecutive transmission
of 11 (×2 PI) wide 90° diverging beam at 250 frames/s was
chosen to acquire perfusion in all the myocardium after a
microbubble destruction sequence.
The large amount of data acquired using HFR CE can be
translated, thorough, e.g., compounding and averaging, too
much superior CANR and CTR between UCA and tissue
than conventional cardiac CE, for up to 48% (3.5 dB) and
13.4-dB improvement, respectively, in vitro, even when the
spatial average peak negative pressure for the HFR CE is 36%
lower than the standard CE. The increase in CTR and CANR
for HFR CE in our results is likely due to the reduction of
speckle (through compounding and averaging) that reduced
the denominator of the CANR and potentially less nonlinear
propagation of ultrasound in deep tissue due to its low peak
negative pressure. However, the NWP evaluation shows that
HFR CE has generated slightly more UCA signal than CE in
the tissue even with a low concentration of UCA. One reason
is that the CE focus point is slightly below the UCA area
then less NWP is generated by the UCA. Another possibility
is the low attenuation of the phantom (0.145 dB/MHz [41])
where second-harmonic signal is not attenuated as much as
in cardiac tissue. As it has been investigated in [48] for
CE acquisition, the NWP effect is the highest when the
transmitted pulse is at the resonant frequency of the UCA.
By reducing the MI or by using higher frequency, the NWP
can be reduced but reducing the contrast. Further investigation
for HFR CE transmission should be realized in order to
optimize HFR CE transmission for lower NWP effect. In vivo,
close to the probe where the local peak negative pressure
of HFR CE is higher or close to CE (Table II), the CANR
and CTR are improved up to 15% and 3.1 dB, respectively,
but decrease near the focus area. Furthermore, thanks to the
HFR of HFR CE, a temporal average, similar to a video
filter, were applied by averaging seven weighted consecutives
HFR CE envelope detected frames (so-called HFR CE SUM 7
or SUM 7) to achieve even further improvement without
compromising the real-time display frame rate. Compared to
CE, the CANR for HFR CE is improved up to 93% (5.7 dB)
while CTR is not impacted by the smoothing effect. It should
be noted that the CANR improvement for SUM7 is greater
in vivo than that in vitro. This is likely due to the effect of
temporal averaging in SUM7 which smooth more the in vivo
chamber since the in vitro chamber did not have significant
flow motion. The improvement in CTR in vivo is lower than
in vitro because of the fast motion of the UCA in the chamber.
Such fast motion reduces coherences between acquisitions
from different steering angles and hence reduces the average
image intensity in the chamber [19], [49].
The improvement for HFR CE over standard CE is despite
of the unfavorable ultrasound pressure field for HFR CE,
where the pressure in deep tissue for HFR CE is up to 4 times
lower than that corresponding to an MI = 0.1 (Table II).
In HFR diverging and plane wave CE, the acoustic pressure
gradually decreases over depth, while in conventional CE with
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Fig. 8. HFR CE 1 and HFR CE SUM 7 myocardium detection images of in vivo experiments at several times (left) and TIC obtain for the corresponding
HFR CE 1 and HFR CE SUM 7 myocardium detection shown on the left and the three different HFR CE acquisitions (right). All TICs are shown with their
corresponding lognormal fit. The three dotted lines in the first TIC correspond to the time position of the HFR CE 1 and HFR CE SUM 7 images.
focused wave the pressure gradually increases toward the focus
before decreasing again (Fig. 2). In this study, a low acoustic
pressure/MI was used for HFR diverging CE. At the 80-mm
CE focus depth, the acoustic peak-negative pressure for
HFR CE is approximately 25% that of its focused counterpart.
The highest peak-negative pressure in HFR CE, which is
close to the transducer surface, is 79 kPa, corresponding to
an MI of 0.06, compared to an MI of 0.11 in the focused
CE sequence. Moreover, the ratio of average pressure between
CE and HFR CE obtained the integral of each curves on Fig. 2,
highlights that HFR CE has 36% lower average peak-negative
pressure compared to CE for each transmission. Similar to
plane wave CEUS imaging, a better contrast can be obtained
with diverging and compounding acquisition [16], [18].
CANR is an image contrast measure to demonstrate the
ability to distinguish echogenicity differences between two
neighboring regions over noises (speckle and other noises).
CANR = 1 means that the image intensity difference between
the two regions is similar to the noise. Here, we use CANR
to demonstrate the ability of different imaging techniques
(CE versus HFR CE) to distinguish image intensity differ-
ences between contrast agent region and its neighboring tissue
region over noises on phantom, and between the chamber and
myocardium in vivo. It should be noted that the two lower parts
of the myocardium (segments 5 and 6) in the in vivo results
have CANRs lower than those of CE and much smaller than
one, and it is difficult to distinguish the myocardium from
the chamber. At these parts of the myocardium, the acoustic
pressure of HFR CE is more than three times lower than that
of CE.
It is noticeable that there are some patterns inside the cham-
ber in Figs. 5 and 6. These are more noticeable in the SUM 7
image and in the supplementary videos provided online. Such
patterns are absent in the conventional CE approach. The
proposed HFR CE method is based on the coherent compound-
ing of diverging waves, similar to the plane wave coherent
Fig. 9. (a) Coherent and (b) incoherent HFR CE SUM 7 images of
in vivo heart sheep experiments. All images are normalized and log compress
by their own maximum and display with a dynamic range of 40 dB. The
maximum depth is 90 mm and the lateral axis cover is 100 mm.
compounding [8], [19]. Any presence of motion could induce
a loss of signal coherence between compounding angles.
If instead of coherent compounding, incoherent compounding
is realized between all angles, the motion artifacts inside the
chamber disappear because of the phase information lost. This
approach is similar to spatial compounding for sector scan
which has been investigated for standard focus transmission
but suffered of low frame rate and a limited field of view [50].
Coherent and incoherent HFR CE SUM 7 compounding are
shown in Fig. 9. A complementary video for Fig. 9 is available
online corresponding to the incoherent HFR CE SUM 7
approach displayed in a fast frame rate. It is visible that motion
artifacts are removed, and wall delineation and valves visual-
ization are improved. The totally incoherent compounding has
potential for chamber segmentation or valves visualization.
However, this approach has some limits such as the image
dynamic range which is significantly reduced, and some fine
details inside the myocardium disappeared.
This loss of signal coherence between angles was analyzed
for several UCA velocities in [18]. For HFR CE diverging
transmission, 11 (×2 PI) angles are transmitted given a
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compounded frame rate of 250 frames/s. Given the velocity
of the myocardium which can reach a velocity of 9.4 cm · s−1
in the case of young healthy humans at rest [51], and the flow
inside the chamber which can be higher than 1 m · s−1, there
will be motion between the data acquisition during the multiple
angle transmissions, and such motion could affect the final
coherent sum, resulting in the image intensity being coded by
flow velocity, in a sense similar to Doppler. This means that
the quantification of image intensity in HFR CE varies with
image settings. While there is motion compensation approach
based on image registration can correct and improve the
contrast-to-noise ratio [49], such patterns due to flow velocity
may potentially hold clinical value for visualizing or even
quantifying flow patterns within the chamber. Some clin-
ical researches have investigated the vortex inside the
heart for heart failure (204 ± 39 frames/s) or LV dysfunction
(80 frames/s) by particle image velocimetry but was limited
by the field of view and the frame-rate acquisition [25], [26].
The frame-rate improvement with the proposed method may
improve the tracking of UCA for vortography especially
during stress acquisition [25], [40], [52], [53]. Furthermore,
the in vivo imaging protocol for HFR CE, including ultrasound
parameters, is far from optimized. For instance, the number
of compounding, the angle width, and the various angles
defining the transmissions would significantly affect the final
image quality specifically the segmentation of the deepest
myocardium segments. These need further in vivo studies for
optimization.
The in vivo experiment shows that the transmission
sequence proposed with the Verasonics system scanner allows
the quantification of myocardium perfusion by the destruction
of the UCAs in the chamber and subsequent the acquisition
of 1000 frames at 250 frames/s. The intensity inside the
myocardium is low after the destruction of the UCA, and then
it reaches a plateau as expected (Fig. 8). A recent random
forest segmentation method is shown to be able to segment
the HFR images and produce an oscillating pattern in the TIC
curves corresponding to the heart rate of the sheep [46]. The
lognormal fit is able to fit the TIC even if in the presence of
this motion [47].
It should be noted that in the in vivo evaluation, the con-
ventional CE and the HFR CE data were acquired on the
same sheep heart but at different time points. This explains the
slightly different shapes of the heart in the two acquisitions.
It should also be noted that while HFR CE has successfully
generated a TIC curve, the corresponding TIC curve of CE
failed. While the better images obtained by HFR CE may
have facilitated the generation of TIC, successful generation
of TICs has been demonstrated by existing clinical systems
that uses line-by-line scanning. The failure of generating TIC
using CE may be due to the nonoptimized imaging parameters,
and also the bolus injection used instead of constant infusion
of microbubbles.
The HFR CE technique, by taking advantages of two most
significant advances in ultrasound, i.e., HFR acquisition and
UCA, is able to acquire a large amount of data from blood
flow/perfusion with high sensitivity, without losing real-time
frame rate. Such data would be able to either potentially
reveal fast flow events not correctly visible using existing
techniques, and/or significantly improve real-time image qual-
ity by combining data from multiple frames. This holds
great potential in imaging cardiac flow and perfusion, by not
only improving the existing applications such as myocardium
perfusion quantification, but also potentially opening up new
opportunities by visualizing fast/subtle features not discernable
in existing techniques and improving wall delineation.
V. CONCLUSION
We have presented and initially evaluated a cardiac HFR CE
imaging system. Initial evaluation has demonstrated that
HFR CE generates superior image quality and has great
potential to significantly improve the current cardiac imaging
of flow and tissue perfusion.
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